2551 - 2600 of 8587 Results
Title
Year
- Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐up2021OPENTitle: Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐upJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2257Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2257Citation Count: 15
- Characterizing resting‐state networks in Parkinson’s disease: A multi‐aspect functional connectivity study2021OPENTitle: Characterizing resting‐state networks in Parkinson’s disease: A multi‐aspect functional connectivity studyJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2101Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2101Citation Count: 13
-
OPENTitle: Psychometric properties of the Beck Depression Inventory‐II in progressive supranuclear palsyJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2344Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2344Citation Count: 13
- Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contrary2021OPENTitle: Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contraryJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/brb3.2220Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2220Citation Count: 7
-
OPENTitle: Olfactory impairment in Wilson’s diseaseJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2022Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2022Citation Count: 14
-
OPENTitle: Comparison between four published definitions of hyposmia in Parkinson's diseaseJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2258Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/brb3.2258Citation Count: 7
- Modelling item scores of Unified Parkinson's Disease Rating Scale Part III for greater trial efficiency2021OPENTitle: Modelling item scores of Unified Parkinson's Disease Rating Scale Part III for greater trial efficiencyJournal Name: British Journal of Clinical PharmacologyPublisher: WileyVol: 87Issue #: 9Start Page: 3608End Page: 3618Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bcp.14777Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.14777Citation Count: 15
-
OPENTitle: Antiepileptogenesis and disease modification: Clinical and regulatory issuesJournal Name: Epilepsia OpenPublisher: WileyVol: 6Issue #: 3Start Page: 483End Page: 492Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/epi4.12526Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/epi4.12526Citation Count: 30
- A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 Mutation2021OPENTitle: A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 MutationJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 110Issue #: 2Start Page: 508End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.2277Citation Count: 13
- Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy2021OPENTitle: Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant EpilepsyJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 110Issue #: 5Start Page: 1368End Page: 1380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/cpt.2408Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2408Citation Count: 31
- The effect of polygenic risk on white matter microstructural degeneration in Parkinson's disease: A longitudinal Diffusion Tensor Imaging study2021RESTRICTEDTitle: The effect of polygenic risk on white matter microstructural degeneration in Parkinson's disease: A longitudinal Diffusion Tensor Imaging studyJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 4Start Page: 1000End Page: 1010Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.15201Citation Count: 4
-
OPENTitle: Worldwide barriers to genetic testing for movement disordersJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: 6Start Page: 1901End Page: 1909Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ene.14826Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14826Citation Count: 35
- Effects of exergaming on hippocampal volume and brain‐derived neurotrophic factor levels in Parkinson’s disease2021OPENTitle: Effects of exergaming on hippocampal volume and brain‐derived neurotrophic factor levels in Parkinson’s diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 2Start Page: 441End Page: 449Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ene.15165Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15165Citation Count: 32
- Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study2021OPENTitle: Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort studyJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: 10Start Page: 3348End Page: 3359Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/ene.14803Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14803Citation Count: 169
-
OPENTitle: Germline Saturation Mutagenesis Induces Skeletal Phenotypes in MiceJournal Name: Journal of Bone and Mineral ResearchPublisher: Oxford University Press (OUP)Vol: 36Issue #: 8Start Page: 1548End Page: 1565Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jbmr.4323Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8862308Citation Count: 8
- Plasma membrane calcium ATPase downregulation in dopaminergic neurons alters cellular physiology and motor behaviour in Drosophila melanogaster2021RESTRICTEDTitle: Plasma membrane calcium ATPase downregulation in dopaminergic neurons alters cellular physiology and motor behaviour in Drosophila melanogasterJournal Name: European Journal of NeurosciencePublisher: WileyVol: 54Issue #: 6Start Page: 5915End Page: 5931Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.15401Citation Count: 5
- Transitioning to telegenetics in the COVID‐19 era: Patient satisfaction with remote genetic counseling in adult neurology2021OPENTitle: Transitioning to telegenetics in the COVID‐19 era: Patient satisfaction with remote genetic counseling in adult neurologyJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 30Issue #: 4Start Page: 974End Page: 983Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jgc4.1470Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jgc4.1470Citation Count: 24
- Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's disease2021RESTRICTEDTitle: Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 158Issue #: 4Start Page: 833End Page: 836Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.15442Citation Count: 9
-
RESTRICTEDTitle: Deep learning‐based scheme to diagnose Parkinson's diseaseJournal Name: Expert SystemsPublisher: WileyVol: 39Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/exsy.12739Citation Count: 46
-
OPENTitle: Differentiation of multiple system atrophy subtypes by gray matter atrophyJournal Name: Journal of NeuroimagingPublisher: WileyVol: 32Issue #: 1Start Page: 80End Page: 89Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/jon.12927Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jon.12927Citation Count: 8
- fISHing with immunohistochemistry for housekeeping gene changes in Alzheimer’s disease using an automated quantitative analysis workflow2020OPENTitle: fISHing with immunohistochemistry for housekeeping gene changes in Alzheimer’s disease using an automated quantitative analysis workflowJournal Name: Journal of NeurochemistryPublisher: WileyVol: 157Issue #: 4Start Page: 1270End Page: 1283Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.15283Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.15283Citation Count: 6
- Alpha‐Synuclein oligomerization and aggregation: All models are useful but only if we know what they model2020OPENTitle: Alpha‐Synuclein oligomerization and aggregation: All models are useful but only if we know what they modelJournal Name: Journal of NeurochemistryPublisher: WileyVol: 157Issue #: 4Start Page: 891End Page: 898Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.15275Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.15275Citation Count: 7
- Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein2021OPENTitle: Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synucleinJournal Name: Journal of Neuroscience ResearchPublisher: WileyVol: 99Issue #: 4Start Page: 1161End Page: 1176Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/jnr.24782Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/jnr.24782Citation Count: 32
- Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease2021OPENTitle: Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 302End Page: 314Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28849Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28849Citation Count: 25
-
OPENTitle: The contribution of behavioral features to caregiver burden in FTLD spectrum disordersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 9Start Page: 1635End Page: 1649Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12494Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9160199Citation Count: 22
- Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum2021OPENTitle: Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuumJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 7Start Page: 1370End Page: 1382Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12480Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12480Citation Count: 33
-
OPENTitle: Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 12Start Page: 1976End Page: 1987Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12353Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12353Citation Count: 81
-
OPENTitle: Different rates of cognitive decline in autosomal dominant and late‐onset Alzheimer diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 10Start Page: 1754End Page: 1764Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12505Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9160203Citation Count: 8
-
RESTRICTEDTitle: Organizations join forces to support early diagnosis of Lewy body dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 6Start Page: 1077End Page: 1078Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.12386Citation Count: 0
- Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease2021OPENTitle: Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 6Start Page: 984End Page: 1004Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12254Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12254Citation Count: 37
-
OPENTitle: Alzheimer's disease alters oligodendrocytic glycolytic and ketolytic gene expressionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 9Start Page: 1474End Page: 1486Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12310Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12310Citation Count: 52
- Monoamine oxidase A inhibition as monotherapy reverses parkinsonism in the MPTP-lesioned marmoset2020RESTRICTEDTitle: Monoamine oxidase A inhibition as monotherapy reverses parkinsonism in the MPTP-lesioned marmosetJournal Name: Naunyn-Schmiedeberg's Archives of PharmacologyPublisher: Springer Science and Business Media LLCVol: 393Issue #: 11Start Page: 2139End Page: 2144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00210-020-01927-wCitation Count: 3
- Monoamine oxidase A inhibition with moclobemide enhances the anti-parkinsonian effect of L-DOPA in the MPTP-lesioned marmoset2020RESTRICTEDTitle: Monoamine oxidase A inhibition with moclobemide enhances the anti-parkinsonian effect of L-DOPA in the MPTP-lesioned marmosetJournal Name: Naunyn-Schmiedeberg's Archives of PharmacologyPublisher: Springer Science and Business Media LLCVol: 393Issue #: 11Start Page: 2157End Page: 2164Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00210-020-01933-yCitation Count: 2
- Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?2020OPENTitle: Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?Journal Name: Neurological Research and PracticePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s42466-020-00076-yBest OA location URL: https://neurolrespract.biomedcentral.com/track/pdf/10.1186/s42466-020-00076-yCitation Count: 3
- A machine learning-based classification approach on Parkinson’s disease diffusion tensor imaging datasets2020OPENTitle: A machine learning-based classification approach on Parkinson’s disease diffusion tensor imaging datasetsJournal Name: Neurological Research and PracticePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s42466-020-00092-yBest OA location URL: https://neurolrespract.biomedcentral.com/track/pdf/10.1186/s42466-020-00092-yCitation Count: 28
-
RESTRICTEDTitle: Segmental dystonia after radical neck dissection and radiotherapy: a case reportJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 42Issue #: 3Start Page: 1215End Page: 1216Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10072-020-04792-wCitation Count: 1
- Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson’s Disease: Expert Review and Commentary2020OPENTitle: Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson’s Disease: Expert Review and CommentaryJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 7End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-020-00220-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-020-00220-5.pdfCitation Count: 46
- Levodopa-carbidopa intestinal gel is an option in Parkinson’s disease with hyponatremia induced by dopamine agonists2020RESTRICTEDTitle: Levodopa-carbidopa intestinal gel is an option in Parkinson’s disease with hyponatremia induced by dopamine agonistsJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 41Issue #: 11Start Page: 3361End Page: 3363Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10072-020-04501-7Citation Count: 3
-
RESTRICTEDTitle: "Eine Impfung wäre viel praktischer als die Infusion von Antikörpern"Journal Name: InFo Neurologie + PsychiatriePublisher: Springer Science and Business Media LLCVol: 22Issue #: 7-8Start Page: 6End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s15005-020-1426-yCitation Count: 0
- Deregulated Automatic Generation Control using Novel Opposition-based Interactive Search Algorithm Cascade Controller Including Distributed Generation and Electric Vehicle2020RESTRICTEDTitle: Deregulated Automatic Generation Control using Novel Opposition-based Interactive Search Algorithm Cascade Controller Including Distributed Generation and Electric VehicleJournal Name: Iranian Journal of Science and Technology, Transactions of Electrical EngineeringPublisher: Springer Science and Business Media LLCVol: 44Issue #: 3Start Page: 1233End Page: 1251Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40998-019-00306-3Citation Count: 39
- Objective measurement in Parkinson’s disease: a descriptive analysis of Parkinson’s symptom scores from a large population of patients across the world using the Personal KinetiGraph®2020OPENTitle: Objective measurement in Parkinson’s disease: a descriptive analysis of Parkinson’s symptom scores from a large population of patients across the world using the Personal KinetiGraph®Journal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-020-00087-6Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-020-00087-6Citation Count: 29
- Creation of a gene expression classifier for predicting Parkinson’s disease rate of progression2020RESTRICTEDTitle: Creation of a gene expression classifier for predicting Parkinson’s disease rate of progressionJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 127Issue #: 5Start Page: 755End Page: 762Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-020-02194-yCitation Count: 7
- Combined mGlu2 orthosteric stimulation and positive allosteric modulation alleviates l-DOPA-induced psychosis-like behaviours and dyskinesia in the parkinsonian marmoset2020RESTRICTEDTitle: Combined mGlu2 orthosteric stimulation and positive allosteric modulation alleviates l-DOPA-induced psychosis-like behaviours and dyskinesia in the parkinsonian marmosetJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 127Issue #: 7Start Page: 1023End Page: 1029Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-020-02185-zCitation Count: 11
- The mGlu2/3 antagonist LY-341,495 reverses the anti-dyskinetic and anti-psychotic effects of the mGlu2 activators LY-487,379 and LY-354,740 in the MPTP-lesioned marmoset2020RESTRICTEDTitle: The mGlu2/3 antagonist LY-341,495 reverses the anti-dyskinetic and anti-psychotic effects of the mGlu2 activators LY-487,379 and LY-354,740 in the MPTP-lesioned marmosetJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 127Issue #: 7Start Page: 1013End Page: 1021Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-020-02196-wCitation Count: 10
- Can kinematic parameters of 3D reach-to-target movements be used as a proxy for clinical outcome measures in chronic stroke rehabilitation? An exploratory study2020OPENTitle: Can kinematic parameters of 3D reach-to-target movements be used as a proxy for clinical outcome measures in chronic stroke rehabilitation? An exploratory studyJournal Name: Journal of NeuroEngineering and RehabilitationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12984-020-00730-1Best OA location URL: https://jneuroengrehab.biomedcentral.com/track/pdf/10.1186/s12984-020-00730-1Citation Count: 10
-
OPENTitle: Microglial burden, activation and dystrophy patterns in frontotemporal lobar degenerationJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-020-01907-0Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-020-01907-0Citation Count: 42
- The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease2020OPENTitle: The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 2Start Page: 448End Page: 454Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-020-10156-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-020-10156-3.pdfCitation Count: 24
-
RESTRICTEDTitle: Benign versus malignant Parkinson disease: the unexpected silver lining of motor complicationsJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 267Issue #: 10Start Page: 2949End Page: 2960Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-020-09954-6Citation Count: 34
-
OPENTitle: Thalamic morphology predicts the onset of freezing of gait in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00163-0Best OA location URL: https://www.nature.com/articles/s41531-021-00163-0.pdfCitation Count: 30
-
OPENTitle: Pallidal stimulation as treatment for camptocormia in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-020-00151-wBest OA location URL: https://www.nature.com/articles/s41531-020-00151-w.pdfCitation Count: 19